EUVIMEDEUVIMED entdecken
Crossref

The role of inflammatory markers and βhCG levels in predicting the success of single‐dose methotrexate treatment in tubal ectopic pregnancy

Zekiye Soykan Sert iD, Mete Bertizlioğlu iD

International Journal of Gynecology & Obstetrics · 2025

DOI: 10.1002/ijgo.16084 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, 2025. Verfasst von Zekiye Soykan Sert und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, Aksaray University Medical School, Aksaray, Turkey. Hauptthemen laut MEDLINE: Methotrexate, Chorionic Gonadotropin, beta Subunit, Human, Pregnancy, Tubal, Abortifacient Agents, Nonsteroidal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate the predictive ability of serum beta human chorionic gonadotropin (βhCG) levels and inflammatory markers derived from hemogram parameters in the success of methotrexate (MTX) treatment for tubal ectopic pregnancy.

Methods

This retrospective study involved the examination of patients diagnosed with tubal ectopic pregnancy and treated with a single dose of MTX at our clinic between 2018 and 2023. The monocyte‐to‐lymphocyte ratio (MLR), neutrophil‐to‐lymphocyte ratio (NLR), platelet‐to‐lymphocyte ratio (PLR), and systemic immune‐inflammation index (SII) were calculated from blood samples taken at the time of presentation. βhCG levels were recorded on days 1, 4, and 7 of treatment. The patients were categorized into successful and unsuccessful treatment groups based on their response to MTX.

Results

No statistically significant differences were found between the two groups regarding MLR, NLR, PLR, or SII values ( P = 0.284, P = 0.097, P = 0.455, and P = 0.061, respectively). In the receiver operating characteristic analysis of serum βhCG from day 1 to day 4, the area under the curve value was calculated as 0.832. The cutoff value for the serum βhCG change from days 1 to 4 was −0.093 (−9.3%), with a sensitivity of 85.53% and specificity of 74.14%, and a positive predictive value (PPV) of 87.5%.

Conclusion

There were no significant differences in inflammatory markers (MLR, NLR, PLR, and SII) between the successful and unsuccessful MTX treatment groups. The change in serum βhCG levels between days 1 and 4 can be used as an early predictor of MTX treatment success in tubal ectopic pregnancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethotrexateChorionic Gonadotropin, beta Subunit, HumanPregnancy, TubalAbortifacient Agents, NonsteroidalHumansFemalePregnancyRetrospective StudiesAdultBiomarkersPredictive Value of TestsTreatment OutcomeROC CurveInflammationNeutrophilsYoung Adult

Stichwörter der Autor:innen

beta human chorionic gonadotropininflammatory markersmethotrexatetubal ectopic pregnancy

Substanzen

MethotrexateChorionic Gonadotropin, beta Subunit, HumanBiomarkersAbortifacient Agents, Nonsteroidal

Autor:innen und Institutionen

  • Department of Gynecology and Obstetrics, Aksaray University Medical School, Aksaray, Turkey.
  • Department of Obstetrics and Gynecology, Konya City Hospital, Konya, Turkey.

ORCID-Profile: Zekiye Soykan Sert, Mete Bertizlioğlu

Zitieren

APA

Soykan Sert, Z., & Bertizlioğlu, M. (2025). The role of inflammatory markers and βhCG levels in predicting the success of single‐dose methotrexate treatment in tubal ectopic pregnancy. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.16084

Vancouver

Soykan Sert Z, Bertizlioğlu M. The role of inflammatory markers and βhCG levels in predicting the success of single‐dose methotrexate treatment in tubal ectopic pregnancy. International Journal of Gynecology & Obstetrics. 2025. doi:10.1002/ijgo.16084

BibTeX
@article{SoykanSert2025,
  author = {Soykan Sert, Zekiye and Bertizlioğlu, Mete},
  title = {The role of inflammatory markers and βhCG levels in predicting the success of single‐dose methotrexate treatment in tubal ectopic pregnancy},
  journal = {International Journal of Gynecology & Obstetrics},
  year = {2025},
  doi = {10.1002/ijgo.16084}
}
Kostenlos starten →